Research
Oppenheimer Downgrades Crescent Capital BDC to Market Perform From Outperform, Adjusts Price Target to $16 From $19
Crescent Capital BDC (CCAP) has an average rating of overweight and mean price target of $14.36, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$CCAP
